C

Constellation Pharmaceuticals

63 employees

Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Biologics
Epigenetics
Genetics
Anitbodies
Medical
Inflammation
Pharmaceutical
Cancer

Date founded

2008

Funding rounds raised

Total raised

$100M

from 27 investors over 27 rounds

C

Constellation Pharmaceuticals raised $65M on October 1, 2019

Investors: The Column Group

C

Constellation Pharmaceuticals raised $40M on March 20, 2019

Investors: Hercules Capital, Inc.

C

Constellation Pharmaceuticals raised $100M on April 9, 2018

Investors: NS Investment, The Column Group, OrbiMed Advisors, S.R. One Ltd, Sirona Capital, Venrock, Solon Mack Capital and Third Rock Ventures

C

Constellation Pharmaceuticals raised $1.3M on December 7, 2017

Investors: Massachusetts Clean Energy Center

C

Constellation Pharmaceuticals raised $49M on July 1, 2017

Investors: Third Rock Ventures, Venrock and The Column Group

C

Constellation Pharmaceuticals raised $55M on December 9, 2015

Investors: Third Rock Ventures, Venrock, Solon Mack Capital and The Column Group

C

Constellation Pharmaceuticals raised undisclosed on September 1, 2012

Investors: The Leukemia & Lymphoma Society

C

Constellation Pharmaceuticals raised $15M on June 6, 2011

Investors: Third Rock Ventures, S.R. One Ltd, Venrock and The Column Group

C

Constellation Pharmaceuticals raised $22M on June 7, 2010

Investors: Third Rock Ventures, Venrock, The Column Group and S.R. One Ltd

FAQ